Abstract
The main advantage of bioprosthetic cardiac valves in comparison to mechanical prosthesis is the lower incidence of antithromboembolic-related hemorrhages. However, bioprostheses have limited durability due to progressive tissue degeneration and calcification resulting in structural valve deterioration (SVD) and suboptimal hemodynamic performances. The Medtronic Mosaic bioprosthesis is a supraannular third-generation stented porcine bioprosthesis which was introduced in 1994. It is built upon the historical durability of the Hancock II valve [1] and technical innovations were incorporated into the design in an attempt to improve hemodynamic performance and durability [2]. Tissue fixation with the Medtronic Physiologic Fixation™ process is performed with glutaraldehyde in order to minimize the consequences of antigenicity after porcine valve implantation [3]. Furthermore, the valve design includes predilatation of the porcine aortic root and using zero net pressure across the leaflets (Fig. 1a) [4]. By this treatment, natural leaflet morphology is generally preserved. The tissue is mounted on a low-profile flexible polymer stent (Fig. 1b) to minimize hemodynamic disturbance and to make it suitable for patients with small aortic root diameters.
This article is a modified version of an article published in 2007 in The Annals of Thoracic Surgery, Vol 83, pp 1310–1318, Riess et al., “Hemodynamic Performance of the Medtronic Mosaic Porcine Bioprothesis Up to Ten Years”. Additional figures were incorporated with permission of the Medtronic Company.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
David TE, Ivanov J, Armstrong S, Feindel CM, Cohen G (2001) Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg 121:268–278
Fradet G, Bleese N, Busse E, Jamieson E, Raudkivi P, Goldstein J, Metras M (2004) The Mosaic valve clinical performance at seven years: results from a multi-center prospective clinical trial. J Heart Valve Dis 13(2):239–247
Carpentier A, Lemaigre G, Robert L, Carpentier S, Dubost C (1969) Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovas Surg 58:467
Vesley I (1991) Analysis of the Medtronic Intact bioprosthesis valve. Effects of zero-pressure fixation. J Thorac Cardiovasc Surg 101:90–99
Duarte IG, MacDonald MJ, Cooper WA et al (2001) In vivo hemodynamic, histologic, and antimineralization charateristics of the Mosaic Bioprosthesis. Ann Thorac Surg 71:92–99
Girardot MN, Girardot JM, Schoen FJ (1991) Alpha amino oleic acid, a new compound, prevents calcification of bioprosthetic heart valves. Trans Soc Biomater 14:114–116
Walther T, Falk V, Diegeler A et al (1999) Effectiveness of different anticalcification treatments for stentless aortic bioprosthesis. Thorac Cardiovasc Surg 47:23–25
Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Wiesel RD (1996) Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 62:932–935
Peto R, Pike MC, Armitage P et al (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 35:1–39
Salomon NW, Okies JE, Krause AH, Page US, Bigelow JC, Colburn LQ (1991) Serial follow-up of an experimental bovine pericardial aortic bioprosthesis. Circulation 84:140–144
David TE, Armstrong S, Sun Z (1992) Clinical and hemodynamic assessment of the Hancock II bioprosthesis. Ann Thorac Surg 54:661–667
McDonald ML, Daly RC, Schaff HV et al (1997) Hemodynamic performance of small aortic valve bioprostheses: Is there a difference? Ann Thorac Surg 63:362–366
Jamieson WR, Janusz MT, Burr LH, Ling H, Miyagishima RT, Germann E (2001) Carpentier-Edwards supraannular porcine bioprosthesis: Second-generation prosthesis in aortic valve replacement. Ann Thorac Surg 71:224–227
Jamieson WRE, Janusz Mt, MacNab J, Henderson C (2001) Hemodynamic comparison of second and third generation stented bioprostheses in aortic valve replacement. Ann Thorac Surg 71:282–284
Wong SP, Legget ME, Greaves SC, Barratt-Boyes BG, Milsom FP, Raudkivi PJ (2000) Early experience with the mosaic bioprosthesis: A new generation porcine valve. Ann Thorac Surg 69:1846–1850
Barratt-Boyes BG, Jaffe WM, Whitlock RM (1998) The Medtronic intact porcine valve: Ten-year clinical review. J Thorac Cardiovasc Surg 116:1005–1014
Jones M, Eidbo EE, Hilbert SL, Ferrans VJ, Clark RE (1989) Anticalcification treatments of bioprosthetic heart valves: In vivo studies in sheep. J Card Surg 4:69–73
Gott JP, Pan-Chih, Dorsey LMA et al (1992) Calcification of porcine valves: A successful new method of antimineralization. Ann Thorac Surg 53:207–216
Melina G, Rubens MB, Birks EJ, Bizzarri F, Khaghani A, Yacoub MH (2000) A quantitative study of calcium deposition in the aortic wall following Medtronic freestyle compared with homograft aortic root replacement. A prospedive randomized Irial. J Heart Valve Dis 9:97–103
Jamieson WRE, Janusz MT, Miyagishima RT et al (1988) Carpentier-Edwards standard porcine bioprostheses — primary tissue failure (structural valve deterioration) by age groups. Ann Thorac Surg 46:155–162
Magilligan DJ, Lewis JW, Stein P, Alam M (1989) The porcine bioprosthetic heart valve: experiences at 15 years. Ann Thorac Surg 48:324–330
Sarris GE, Robbins RC, Miller DC, Mitchell RS, Moore KA, Stinson EB, Oyer PE, Reitz BA, Shumway NE (1993) Randomized, prospective assessment of bioprosthetic valve durability. Hancock versus Carpentier-Edwards valves. Circulation 88(5 Pt 2):II55–II64
Jamieson WRE, Allen P, Miyagishima RT, Gerein AN, Munro AI, Burr LH et al (1990) The Carpentier-Edwards standard porcine bioprosthesis: a first-generation tissue valve with excellent longterm clinical performance. J Thorac Cardiovasc Surg 99:543–561
Jones EL, Weintraub WS, Craver JM, Guyton RA, Cohen CL, Corrigan VE, Hatcher CR (1990) Ten-year experience with the porcine bioprosthetic valve: inter-relationship of valve survival and patient survival in 1050 valve replacements. Ann Thorac Surg 49:370–384
Pelletier LC, Carrier M, Leclerc Y, Dyrda I (1995) The Carpentier-Edwards pericardial bioprosthesis: clinical experience with 600 patients. Ann Thorac Surg 60 (2 Suppl): 297–302
Poirier NC, Pelletier LC, Pellerin M, Carrier M (1998) 15 year experience willi the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg 66:57–61
Jamieson WR, Munro AI, Miyagishima RT, Allen P, Burr LH, Tyers GF (1995) Carpentier-Edwards standard porcine bioprosthesis: Clinical performance to seventeen years. Ann Thorac Surg 60:999–1006
Akins CW, Carroll DL, Buckley MJ, Daggett WM, Hilgenberg AD, Austen WG (1990) Late results with Carpentier-Edwards porcine bioprosthesis. Circulation 82(Suppl IV):65–74
Banbury MK, Cosgrove DM, III, Lytle BW, Smedira NG, Sabik JF, Saunders CR (1998) Long-term results of the Carpentier-Edwards pericardial aortic valve: a 12 year follow-up. Ann Thorac Surg 66:S73–S76
Frater RW, Furlong P, Cosgrove DM et al (1998) Longterm durability and patient functional status of die Carpentier-Edwards perimount pericardial bioprosthesis in the aortic position. J Heart Valve Dis 7:48–53
Myken PS, Caidahl K, Larsson S, Berggren HE (1994) 10-year experience with the Biocor porcine bioprosthesis in the aortic position. J Heart Valve Dis 3:648–656
Dellgren G, Eriksson MJ, Brodin LA, Radegran K (2002) Eleven years’ experience with the Biocor stentless aortic bioprosthesis: Clinical and hemodynamic follow-up with long-term relative survival rate. Eur J Cardiothorac Surg 22:912–921
Bernal JM, Rabasa JM, Lopez R, Nistal JF, Muniz R, Revuelta JM (1995) Durability of the Carpentier-Edwards porcine bioprosthesis: Role of age and valve position. Ann Thorac Surg 60:S248–S252
Gansera B, Botzenhardt F, Grünzinger R, Spiliopoulos K, Angelis I, Kemkes BM (2003) The Mosaic bioprosthesis in aortic position: seven years’ results. J Heart Valve Disease 12:354–361
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Riess, FC. et al. (2010). Clinical results including hemodynamic performance of the Medtronic Mosaic porcine bioprosthesis up to ten years. In: Yankah, C.A., Weng, Y., Hetzer, R. (eds) Aortic Root Surgery. Steinkopff. https://doi.org/10.1007/978-3-7985-1869-8_34
Download citation
DOI: https://doi.org/10.1007/978-3-7985-1869-8_34
Publisher Name: Steinkopff
Print ISBN: 978-3-7985-1868-1
Online ISBN: 978-3-7985-1869-8
eBook Packages: MedicineMedicine (R0)